Isolation and characterization of human monoclonal antibodies against hepatitis C Virus envelope glycoproteins

Journal of Medical Virology

Volumn 55, Issue 1, 1998, Pages 28-34

  Da Silva Cardoso, Marcia ^a,c   Siemoneit, Karl ^a   Sturm, Daniela ^a   Krone, Christoph ^a   Moradpour, Darius ^b   Kubanek, Bernhard ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c DRK Blutspendezentrale Ulm   (Germany)

Author keywords

Baculovirus; Hepatitis; Immunofluorescence; Monoclonal antibodies; Recombinant antigens; Vaccinia virus

Indexed keywords

ARTICLE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; VIRUS CHARACTERIZATION; VIRUS ENVELOPE; VIRUS ISOLATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE; CRICETINAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOBLOTTING; TUMOR CELLS, CULTURED; VIRAL ENVELOPE PROTEINS;

HEPATITIS C VIRUS; HUMAN HERPESVIRUS 4; RNA VIRUSES; UNIDENTIFIED BACULOVIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0031803105     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199805)55:1<28::AID-JMV6>3.0.CO;2-Q     Document Type: Article

References (22)

1. Cardoso MS, Koerner K, Epple S, Dengler T, Kerowgan M, Kubanek B (1996): HCV transmission through blood transfusion: Are HCV-RNA titer in donor serum and genotype major determinants of infection outcome? Beitr Infusionsther Transfusionsmed 33:225-230.
2. Carroll WL, Thilemens K, Dilley J, Levy R (1986): Mouse x human heterohybridomas as fusion partners with human B cell tumors. Journal of Immunological Methods 77:305-319.
3. Choo Q-L, Kuo G, Ralston R, Weiner A, Chien D, Van Nest G, Han J, Berger K, Thudium K, Kuo C, Kansopon J, McFarland J, Tabrizi A, Ching K, Moss B, Cummins LB, Houghton M, Muchmore E (1994): Vaccination of chimpanzees against infection by the hepatitis C virus. Proceedings of the National Academy of Sciences (U.S.A.) 91:1294-1298.
4. da Silva Cardoso M, Sturm D, Koerner K, Dengler T, Kerowgan M, Kubanek B (1997): Anti-HCV envelope prevalence in blood donors from Baden-Württemberg. Annals of Hematology 74:135-137.
5. Dubuisson J, Hsu HH, Cheung RC, Greenberg HB, Russel DG, Rice CM (1994): Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. Journal of Virology 68:6147-6160.
6. Kato N, Ootsuyama Y, Ohkoshi S, Nakazawa T, Sekiya H, Hijikata M, Shimotohno K (1992): Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus. Biochemical Biophysics Research Communications 189:119-127.
7. Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, Ohkoshi S, Shimitohno K (1993): Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. Journal of Virology 67:3923-3930.
8. Kumar U, Monjardino J, Thomas H (1994): Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agamma-globulinemic patient. Gastroenterology 106:1072-1075.
9. Laemmli UK (1970): Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680-685.
10. Lanford R, Notvall L, Chavez D, White R, Frenzel G, Simonsen C, Kim JS (1993): Analysis of hepatitis C virus capsid, E1, and E2/ NS1 proteins expressed in insect cells. Virology 197:225-235.
11. Lau JYN, Krawczynski K, Negro F, Gonzalez-Peralta RP (1996): In situ detection of hepatitis C virus: A critical appraisal. Journal of Hepatology 24:43-51.
12. Lesniewski R, Okasinski G, Carrick R, Van Sant C, Desai S, Johnson R, Scheffel J, Moore B, Mushahwar I (1995): Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: A new marker of HCV infection closely associated with viremia. Journal of Medical Virology 45:415-422
13. Matsuura Y, and Miyamura T (1993): The molecular biology of hepatitis C virus. Seminars in Virology 4:297-304.
14. Moradpour D, Englert C, Wakita T, Wands JR (1996): Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 222:51-63.
15. Rosa D, Campagnoli S, Moretto C. Guenzi E, Cousens L, Chin M, Dong C, Weiner AJ, Lau JYN, Choo Q-L, Chien D, Pileri P, Houghton M, Abrignani S (1996): A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proceedings of the National Academy of Sciences (U.S.A.) 93:1759-1763.
16. Saito T, Sherman GJ, Kurokohchi K, Guo Z-P, Donets M, Yu M-YW, Berzofsky JA, Akatsuka T, Feinstone SM (1997): Plasmid DNA-based immunization for hepatitis C virus structural proteins: Immune responses in mice. Gastroenterology 112:1321-1330.
17. Siemoneit K, da Silva Cardoso M, Wölpl A, Koerner K, Kubanek B (1994): Isolation and characterization of human monoclonal antibodies to hepatitis C virus core antigen. Hybridoma 13:9-13.
18. Siemoneit K, da Silva Cardoso M, Koerner K, Wölpl A, Kubanek B (1995): Human monoclonal antibodies for the immunological characterization of a highly conserved protein domain of the hepatitis C virus glycoprotein E1. Clinical and Experimental Immunology 101:278-283.
19. Towbin H, Staehelin T, Gordon J (1979): Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proceedings of the National Academy of Sciences (U.S.A.) 76:4350-4354.
20. Weiner AJ, Geysen M, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, Brunetto M, Barr PJ, Miyamura T, McHutchinson J, Houghton M (1992): Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections. Proceedings of the National Academy of Sciences (U.S.A.) 89:3468-3472.
21. Zibert A, Schreier E, Roggendorf M (1995): Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 208:653-661.
22. Zibert A, Kraas W, Meisel H, Jung G, Roggendorf M (1997): Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus. Journal of Virology 71:4123-4127.